Related Experiment Videos
Pathophysiology of obstructive nephropathy in the newborn
1Department of Pediatrics, University of Virginia, Charlottesville 22908, USA.
Seminars in Nephrology
|November 18, 1998
Summary
Neonatal unilateral ureteral obstruction impairs kidney development, causing tubular atrophy and fibrosis. Early intervention with growth factors like EGF may mitigate damage and improve long-term kidney function.
Area of Science:
- Developmental biology
- Nephrology
- Cellular biology
Background:
- Congenital obstructive nephropathy results from abnormal urinary tract development, leading to renal growth failure.
- This condition manifests as progressive tubular atrophy and interstitial fibrosis.
- Neonatal kidney development differs significantly from adult responses to obstruction.
Purpose of the Study:
- To investigate the cellular and physiological responses to unilateral ureteral obstruction (UUO) in neonatal rodents.
- To understand the mechanisms underlying impaired renal growth and tubular atrophy in congenital obstructive nephropathy.
- To explore potential therapeutic targets for improving outcomes in affected infants.
Main Methods:
- Studied unilateral ureteral obstruction (UUO) in neonatal guinea pigs, rats, and mice.
- Analyzed renal cellular proliferation, apoptosis, and growth factors.
- Examined the role of epidermal growth factor (EGF) and transforming growth factor-beta1 (TGF-beta1).
Main Results:
- Neonatal UUO reduces nephrogenesis, glomerular maturation, and tubular proliferation, unlike in adults.
- Impaired growth and atrophy are linked to increased tubular apoptosis, reduced bcl-2 and EGF, and elevated TGF-beta1.
- EGF infusion counteracted apoptosis and reduced fibrosis, while TGF-beta1 was regulated by the activated renin-angiotensin system.
Conclusions:
- Neonatal obstructive nephropathy severely impacts kidney development through apoptosis and altered growth factor expression.
- The renin-angiotensin system plays a key role in regulating TGF-beta1 activation post-obstruction.
- Understanding these cellular mechanisms is crucial for developing targeted therapies for congenital urinary tract obstruction.